Drug intelligence / Profile preview

morus nigra leaf extract

Development stage
Preclinical
Administration
Oral, Topical
01

Overview

Morus nigra leaf extract is a phytochemical mixture derived from the leaves of the black mulberry tree (Morus nigra). It contains various bioactive compounds including glycosylated flavonoids (kaempferol-3-O-glycoside, quercetin-3-O-glycoside), β-sitosterol, phenolic compounds, and anthocyanins[2][1]. The extract has demonstrated **antidiabetic, antinociceptive (pain-reducing), hepatoprotective, antidepressant-like, antibacterial, antioxidant, and potential anticancer effects** in preclinical studies[1][3][11][7][9][8]. Mechanisms of action include inhibition of carbohydrate-digesting enzymes (leading to slower glucose absorption), reduction of inflammatory cytokines, enhancement of anti-inflammatory cytokines, antioxidative effects, and cytotoxic effects against cancer cell lines[1][3][11][8]. Morus nigra leaf extracts have also been investigated in animal models for protection against oxidative stress and hepatic injury[1]. The extract is primarily used in traditional and alternative medicine, and is marketed as an ingredient in dietary supplements and cosmetics, especially for skin lightening and anti-acne purposes[4][10]. It is not an approved pharmaceutical drug.

Other names
Morus nigra leaf extractMulberry Leaf extractMulberry extract (Morus nigra)
02

Targets

IL-6 (Interleukin 6)NF-κBSucrase-Isomaltase

Beyond the preview

Go deeper on morus nigra leaf extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morus nigra leaf extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call